Revvity, Inc. (NYSE:RVTY) Shares Bought by Creative Planning

Creative Planning lifted its stake in shares of Revvity, Inc. (NYSE:RVTY) by 2.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 20,308 shares of the company’s stock after purchasing an additional 451 shares during the quarter. Creative Planning’s holdings in Revvity were worth $2,594,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in RVTY. CX Institutional increased its position in Revvity by 1.1% in the third quarter. CX Institutional now owns 7,984 shares of the company’s stock worth $1,020,000 after buying an additional 86 shares during the period. Exchange Traded Concepts LLC grew its position in shares of Revvity by 2.2% during the third quarter. Exchange Traded Concepts LLC now owns 9,088 shares of the company’s stock worth $1,161,000 after acquiring an additional 193 shares during the last quarter. Gateway Investment Advisers LLC increased its holdings in shares of Revvity by 942.5% in the 3rd quarter. Gateway Investment Advisers LLC now owns 38,081 shares of the company’s stock worth $4,865,000 after acquiring an additional 34,428 shares during the period. Guinness Asset Management LTD lifted its position in Revvity by 7.7% in the 3rd quarter. Guinness Asset Management LTD now owns 3,863 shares of the company’s stock valued at $493,000 after purchasing an additional 276 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt boosted its stake in Revvity by 686.3% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,604 shares of the company’s stock valued at $205,000 after purchasing an additional 1,400 shares during the period. Institutional investors own 86.65% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on RVTY shares. Citigroup lifted their price target on Revvity from $135.00 to $145.00 and gave the company a “buy” rating in a report on Tuesday, July 30th. Leerink Partners boosted their price target on Revvity from $130.00 to $135.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Wells Fargo & Company assumed coverage on Revvity in a report on Tuesday, August 27th. They set an “equal weight” rating and a $130.00 price target on the stock. Bank of America increased their target price on shares of Revvity from $118.00 to $127.00 and gave the company a “neutral” rating in a research report on Tuesday, July 30th. Finally, Barclays upgraded shares of Revvity from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $125.00 to $140.00 in a research report on Tuesday, October 15th. Seven research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Revvity has an average rating of “Moderate Buy” and an average price target of $127.20.

Insider Activity at Revvity

In other Revvity news, insider Joel S. Goldberg sold 3,500 shares of Revvity stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $117.86, for a total transaction of $412,510.00. Following the transaction, the insider now directly owns 33,400 shares in the company, valued at approximately $3,936,524. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, insider Tajinder S. Vohra sold 2,153 shares of the stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $122.09, for a total value of $262,859.77. Following the completion of the sale, the insider now directly owns 23,960 shares of the company’s stock, valued at $2,925,276.40. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Joel S. Goldberg sold 3,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $117.86, for a total transaction of $412,510.00. Following the transaction, the insider now directly owns 33,400 shares in the company, valued at $3,936,524. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 7,807 shares of company stock worth $937,576. 0.60% of the stock is owned by corporate insiders.

Revvity Price Performance

Shares of NYSE:RVTY opened at $116.33 on Friday. The company has a market capitalization of $14.35 billion, a PE ratio of 84.30, a price-to-earnings-growth ratio of 3.27 and a beta of 1.05. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.98 and a current ratio of 2.27. The stock has a fifty day moving average of $121.51 and a 200-day moving average of $113.49. Revvity, Inc. has a one year low of $79.50 and a one year high of $128.15.

Revvity (NYSE:RVTY) last announced its earnings results on Monday, July 29th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.12 by $0.10. The business had revenue of $691.70 million during the quarter, compared to the consensus estimate of $690.33 million. Revvity had a return on equity of 7.34% and a net margin of 6.26%. Revvity’s revenue was down 2.5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.21 earnings per share. As a group, equities analysts anticipate that Revvity, Inc. will post 4.75 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 7th. Stockholders of record on Friday, January 17th will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, January 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.24%. Revvity’s dividend payout ratio is currently 20.29%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.